Stifel notes Angelalign (AGLFF) reported FY24 results this morning, and the firm’s main takeaway relates to Align Technology (ALGN), where it believes Angel’s second half of 2024 implied case volume results support its view that the rate of Invisalign share losses globally are abating. A concern among Align’s investors has been what Angel’s ex-China expansion could mean for Invisalign, but Stifel was “not overly impressed” with Angel’s second half of 2024 case volume of 83,100. The firm has a Buy rating on Align Technology.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGN:
- Align Technology price target lowered to $235 from $270 at Piper Sandler
- Align Technology launches Align X-ray Insights in EU, UK
- Align Tech: Buy Rating Affirmed Amidst Market Volatility and Growth Potential
- Align Technology announces $225M open market repurchase
- Align Tech Completes $1 Billion Stock Buyback